{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T23:33:45Z","timestamp":1774740825798,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1053\/j.seminhematol.2024.10.007","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T05:55:25Z","timestamp":1730267725000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Melanoma antigen genes (MAGE); novel functional targets in multiple myeloma"],"prefix":"10.1053","volume":"62","author":[{"given":"Anna Huo-Chang","family":"Mei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-5757","authenticated-orcid":false,"given":"Hearn Jay","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2024.10.007_bib0001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1034\/j.1600-065X.2002.18803.x","article-title":"Cancer\/testis antigens: an expanding family of targets for cancer immunotherapy","volume":"188","author":"Scanlan","year":"2002","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.10.007_bib0002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2004-12-4931","article-title":"The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3\/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation","volume":"106","author":"Jungbluth","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.10.007_bib0003","first-page":"9","article-title":". Expression of cancer\/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease","volume":"3","author":"Dhodapkar","year":"2003","journal-title":"Cancer Immun"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.10.007_bib0004","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2006-04-014480","article-title":"Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation","volume":"109","author":"Atanackovic","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.10.007_bib0005","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00262-012-1285-6","article-title":"Cancer\/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients","volume":"61","author":"Inaoka","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.10.007_bib0006","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/1471-2407-11-416","article-title":"An overview of cancer\/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients","volume":"11","author":"Inaoka","year":"2011","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.10.007_bib0007","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41588-024-01853-0","article-title":"Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes","volume":"56","author":"Skerget","year":"2024","journal-title":"Nat Genet"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.10.007_bib0008","doi-asserted-by":"crossref","first-page":"727","DOI":"10.18632\/oncotarget.27488","article-title":"MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21(Cip1)","volume":"11","author":"Mei","year":"2020","journal-title":"Oncotarget"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.10.007_bib0009","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1158\/1078-0432.CCR-08-0989","article-title":"Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma","volume":"15","author":"Atanackovic","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.10.007_bib0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jnr.10160","article-title":"The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease","volume":"67","author":"Barker","year":"2002","journal-title":"J Neurosci Res"},{"issue":"14","key":"10.1053\/j.seminhematol.2024.10.007_bib0011","first-page":"5544","article-title":"An overview of the MAGE gene family with the identification of all human members of the family","volume":"61","author":"Chomez","year":"2001","journal-title":"Cancer Res"},{"issue":"7031","key":"10.1053\/j.seminhematol.2024.10.007_bib0012","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature03440","article-title":"The DNA sequence of the human X chromosome","volume":"434","author":"Ross","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.10.007_bib0013","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/geno.1998.5638","article-title":"A new family of mouse genes homologous to the human MAGE genes","volume":"55","author":"De Plaen","year":"1999","journal-title":"Genomics"},{"issue":"14","key":"10.1053\/j.seminhematol.2024.10.007_bib0014","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.93.14.7149","article-title":"The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation","volume":"93","author":"De Smet","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.10.007_bib0015","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/MCB.19.11.7327","article-title":"DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter","volume":"19","author":"De Smet","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.10.007_bib0016","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/1541-7786.MCR-05-0229","article-title":"Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells","volume":"4","author":"Wischnewski","year":"2006","journal-title":"Mol Cancer Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.10.007_bib0017","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.dnarep.2009.01.009","article-title":"The Yin and Yang of the MMS21-SMC5\/6 SUMO ligase complex in homologous recombination","volume":"8","author":"Potts","year":"2009","journal-title":"DNA Repair (Amst)"},{"issue":"16","key":"10.1053\/j.seminhematol.2024.10.007_bib0018","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1128\/MCB.25.16.7021-7032.2005","article-title":"Human MMS21\/NSE2 is a SUMO ligase required for DNA repair","volume":"25","author":"Potts","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.10.007_bib0019","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0896-6273(00)00036-2","article-title":"NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis","volume":"27","author":"Salehi","year":"2000","journal-title":"Neuron"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.10.007_bib0020","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s003350010116","article-title":"Cell- and stage-specific expression of mage genes during mouse spermatogenesis","volume":"11","author":"Clotman","year":"2000","journal-title":"Mamm Genome"},{"issue":"16","key":"10.1053\/j.seminhematol.2024.10.007_bib0021","first-page":"3478","article-title":"Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis","volume":"55","author":"Takahashi","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.10.007_bib0022","doi-asserted-by":"crossref","first-page":"26735","DOI":"10.1038\/srep26735","article-title":"The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice","volume":"6","author":"Hou","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.10.007_bib0023","doi-asserted-by":"crossref","first-page":"eaav4832","DOI":"10.1126\/sciadv.aav4832","article-title":"MAGE cancer-testis antigens protect the mammalian germline under environmental stress","volume":"5","author":"Fon Tacer","year":"2019","journal-title":"Sci Adv"},{"key":"10.1053\/j.seminhematol.2024.10.007_bib0024","first-page":"12","article-title":"Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)","volume":"6","author":"Cho","year":"2006","journal-title":"Cancer Immun"},{"key":"10.1053\/j.seminhematol.2024.10.007_bib0025","first-page":"4","article-title":"Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients","volume":"10","author":"Lendvai","year":"2010","journal-title":"Cancer Immun"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.10.007_bib0026","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1073\/pnas.0707140104","article-title":"Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming","volume":"105","author":"Atanackovic","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.10.007_bib0027","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/JTO.0000000000000653","article-title":"Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer","volume":"10","author":"Pujol","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.10.007_bib0028","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.4049\/jimmunol.0900903","article-title":"Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination","volume":"183","author":"Tsuji","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.10.007_bib0029","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/2326-6066.CIR-18-0198","article-title":"Autologous lymphocyte infusion supports tumor antigen vaccine-induced immunity in autologous stem cell transplant for multiple myeloma","author":"Cohen","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.10.007_bib0030","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/blood-2010-08-299396","article-title":"Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma","volume":"117","author":"Rapoport","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.10.007_bib0031","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/nm1310","article-title":"Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer","volume":"11","author":"Rapoport","year":"2005","journal-title":"Nat Med"},{"issue":"29","key":"10.1053\/j.seminhematol.2024.10.007_bib0032","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1200\/JCO.2017.74.5463","article-title":"Treatment of patients with metastatic cancer using a major histocompatibility complex class II-restricted T-cell receptor targeting the cancer germline antigen MAGE-A3","volume":"35","author":"Lu","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.10.007_bib0033","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1158\/1078-0432.CCR-14-1559","article-title":"Adoptive transfer of MAGE-A4 T-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal cancer","volume":"21","author":"Kageyama","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.10.007_bib0034","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminhematol.2024.10.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108632","article-title":"Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma","volume":"112","author":"Shi","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.10.007_bib0036","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1158\/0008-5472.CAN-10-2442","article-title":"Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer","volume":"71","author":"Rao","year":"2011","journal-title":"Cancer Res"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.10.007_bib0037","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1182\/blood-2009-11-249474","article-title":"Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia","volume":"116","author":"Goodyear","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.10.007_bib0038","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.10.007_bib0039","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CJI.0b013e3182829903","article-title":"Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy","volume":"36","author":"Morgan","year":"2013","journal-title":"J Immunother"},{"issue":"30","key":"10.1053\/j.seminhematol.2024.10.007_bib0040","doi-asserted-by":"crossref","first-page":"11160","DOI":"10.1073\/pnas.0510834103","article-title":"MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents","volume":"103","author":"Monte","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"37","key":"10.1053\/j.seminhematol.2024.10.007_bib0041","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1038\/onc.2014.45","article-title":"Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer","volume":"33","author":"Wong","year":"2014","journal-title":"Oncogene"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.10.007_bib0042","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1158\/0008-5472.CAN-10-1341","article-title":"Mage-A cancer\/testis antigens inhibit p53 function by blocking its interaction with chromatin","volume":"70","author":"Marcar","year":"2010","journal-title":"Cancer Res"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.10.007_bib0043","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1158\/0008-5472.CAN-07-1478","article-title":"MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.10.007_bib0044","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","article-title":"MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases","volume":"39","author":"Doyle","year":"2010","journal-title":"Molecular Cell"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.10.007_bib0045","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1038\/oncsis.2017.21","article-title":"MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation","volume":"6","author":"Jin","year":"2017","journal-title":"Oncogenesis"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.10.007_bib0046","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1080\/15548627.2015.1034420","article-title":"Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancer","volume":"11","author":"Pineda","year":"2015","journal-title":"Autophagy"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.10.007_bib0047","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cell.2015.01.034","article-title":"Degradation of AMPK by a cancer-specific ubiquitin ligase","volume":"160","author":"Pineda","year":"2015","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2024.10.007_bib0048","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-10-1820","article-title":"MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of bax and maintenance of survivin","volume":"17","author":"Nardiello","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.10.007_bib0049","doi-asserted-by":"crossref","first-page":"11345","DOI":"10.1158\/0008-5472.CAN-05-2159","article-title":"Mutually exclusive cyclin-dependent kinase 4\/cyclin D1 and cyclin-dependent kinase 6\/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma","volume":"65","author":"Ely","year":"2005","journal-title":"Cancer Res"},{"issue":"19","key":"10.1053\/j.seminhematol.2024.10.007_bib0050","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1182\/bloodadvances.2017007427","article-title":"A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma","volume":"1","author":"Chari","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.10.007_bib0051","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3324\/haematol.2009.014464","article-title":"Cancer-testis antigens MAGE-C1\/CT7 and MAGE-A3 promote the survival of multiple myeloma cells","volume":"95","author":"Atanackovic","year":"2009","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.10.007_bib0052","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/leu.2017.197","article-title":"Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma","volume":"32","author":"Lagana","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.10.007_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148762","article-title":"Structures of two melanoma-associated antigens suggest allosteric regulation of effector binding","volume":"11","author":"Newman","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.10.007_bib0054","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1038\/s41467-020-18708-x","article-title":"Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"issue":"36","key":"10.1053\/j.seminhematol.2024.10.007_bib0055","doi-asserted-by":"crossref","first-page":"24884","DOI":"10.1021\/jacs.4c05393","article-title":"Development of ligands and degraders targeting MAGE-A3","volume":"46","author":"Li","year":"2024","journal-title":"J Am Chem Soc"},{"key":"10.1053\/j.seminhematol.2024.10.007_bib0056","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1034\/j.1600-065X.2003.00065.x","article-title":"Cell-cycle control of plasma cell differentiation and tumorigenesis","volume":"194","author":"Chen-Kiang","year":"2003","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.10.007_bib0057","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2018.03.026","article-title":"Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 Blockade","volume":"173","author":"Shukla","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.10.007_bib0058","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4331\/wjbc.v5.i3.308","article-title":"KAPtain in charge of multiple missions: Emerging roles of KAP1","volume":"5","author":"Cheng","year":"2014","journal-title":"World J Biol Chem"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.10.007_bib0059","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/21541248.2016.1161698","article-title":"SUMO wrestling with Ras","volume":"7","author":"Zhang","year":"2016","journal-title":"Small GTPases"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324001240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324001240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T14:07:45Z","timestamp":1741961265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324001240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0037196324001240"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.10.007","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma antigen genes (MAGE); novel functional targets in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}